U.S. markets closed
  • S&P 500

    4,577.10
    +64.06 (+1.42%)
     
  • Dow 30

    34,639.79
    +617.75 (+1.82%)
     
  • Nasdaq

    15,381.32
    +127.27 (+0.83%)
     
  • Russell 2000

    2,206.33
    +58.91 (+2.74%)
     
  • Crude Oil

    67.10
    +1.53 (+2.33%)
     
  • Gold

    1,769.40
    -14.90 (-0.84%)
     
  • Silver

    22.41
    +0.07 (+0.32%)
     
  • EUR/USD

    1.1303
    -0.0019 (-0.17%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • GBP/USD

    1.3303
    +0.0026 (+0.19%)
     
  • USD/JPY

    113.1700
    +0.3900 (+0.35%)
     
  • BTC-USD

    56,936.59
    +306.09 (+0.54%)
     
  • CMC Crypto 200

    1,448.85
    +9.97 (+0.69%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,753.37
    -182.25 (-0.65%)
     

Valeant to report first-quarter results on June 7

May 31 (Reuters) - Valeant Pharmaceuticals Inc , which has come under scrutiny for its business and accounting practices, said on Tuesday it would host a conference call on June 7 to discuss first-quarter results.

The Beleaguered Canadian drugmaker reiterated that it expects to file its quarterly report with U.S. and Canadian regulators on or before June 10, ahead of a July 31 deadline.

The troubled drugmaker filed its 2015 financial report in late April, allaying concerns about a possible default on its debt of more than $30 billion.

The company missed an original March 15 deadline, citing an in-house review of its accounting practices. The probe found problems dating back to 2014.

(Reporting by Arathy S Nair in Bengaluru)